Editor Springer Nature Staff
From the Editors

The Clinical Pipeline - a new column from Nature Medicine

Our new fortnightly column will analyse the latest in translational and clinical research, from bench to bedside
Published in Healthcare & Nursing
Go to the profile of Ben Johnson
Ben Johnson
Senior Magazine Editor, Nature Medicine, Springer Nature
The Clinical Pipeline - a new column from Nature Medicine
Like
Go to the profile of Evelina Satkevic
Go to the profile of Sorrel Bunting

This week Nature Medicine published the third in a new fortnightly column called The Clinical Pipeline.

Our goal is to further strengthen the journal's coverage of translational and clinical research, from bench to bedside, and so each column will analyse a recent clinical trial announcement, preprint, or journal publication (with all the caveats that apply to non-peer reviewed research!)

Thiago Carvalho is writing these articles for us, as an experienced Nature Medicine freelancer and author of our COVID Research in Brief articles during the pandemic.

Thiago's first column covered BioNTech’s new combination mRNA / CAR-T cancer vaccine; the second column discussed the unknown efficacy of the antiviral, tecovirimat, against monkeypox; and today's column covers how the FDA are using biomarker data in the approval of new drugs for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

This is something of an experiment for the journal, so please let us know if you found them interesting and/or useful - or any other feedback!

Go to the profile of Ben Johnson
Ben Johnson
Senior Magazine Editor, Nature Medicine, Springer Nature

I trained as a virologist, starting with an undergraduate degree in virology from the University of Warwick, UK. My PhD, in influenza virus genetics and immunoevasion, was from Public Health England and the University of Reading, UK, with Maria Zambon and Wendy Barclay. My research interests then moved to smallpox vaccines, viral ion channels and cell adhesion, while a postdoc at Imperial College London with Geoffrey Smith, FRS. I then joined open-access publisher BioMed Central in 2011 as an editor and then associate publisher and was Head of Communities & Engagement at Springer Nature from 2016, running the Nature Research Communities and other online engagement activities for researchers. I joined Nature Medicine in 2021, with responsibility for news and opinion content, and am based in the London office.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Sign In Register

Follow the Topic

Health Care
Life Sciences > Health Sciences > Health Care
  • Nature Medicine Nature Medicine

    This journal encompasses original research ranging from new concepts in human biology and disease pathogenesis to new therapeutic modalities and drug development, to all phases of clinical work, as well as innovative technologies aimed at improving human health.

    More about the journal

Recommended Content

Cookies

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website. You can decide for yourself which categories you want to deny or allow. Please note that based on your settings not all functionalities of the site are available.

Further information can be found in our privacy policy.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.